The abstract is read at the publisher; the summary is JClub's.
DPB is a covalent molecular glue that selectively kills p53-deficient NSCLC by recruiting RPS7 to MKRN2, enabling RPS7 ubiquitination and proteasomal degradation.
- Why it matters: p53 loss in NSCLC limits effective therapy and targeted protein degradation is constrained by a small set of usable E3 ligases.
- What they did: The study tested DPB cytotoxicity in p53 wild-type versus p53-deficient NSCLC cells and orthotopic mouse models, then used QTRP, biophysical validation, and co-immunoprecipitation-mass spectrometry to map MKRN2 targeting and RPS7 recruitment.
- The result: DPB covalently modified MKRN2 at Cys335 and induced acute nucleolar stress and apoptosis via an MKRN2–RPS7 axis, with synthetic lethality entirely dependent on this pathway.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.